(Dimethylamino)acetaldehyde Diethyl Acetal CAS 3616-56-6 Ịdị Ọcha>99.0% (GC) Afatinib Dimaleate Intermediate Factory
Ruifu Chemical Supply Intermediates of Afatinib
Afatirib CAS 439081-18-2
Afatinib Dimaleate CAS 850140-73-7
(S)-(+)-3-Hydroxytetrahydrofuran CAS 86087-23-2
(Dimethylamino) acetaldehyde Diethyl Acetal CAS 3616-56-6
trans-4-Dimethylaminocrotonic Acid Hydrochloride CAS 848133-35-7
Diethylphosphonoacetic Acid CAS 3095-95-2
7-Fluoro-6-Nitroquinazolin-4(1H) -otu CAS 162012-69-3
7-Chloro-6-Nitro-4-Hydroxyquinazoline CAS 53449-14-2
N-(3-Chloro-4-Fluorophenyl)-7-Fluoro-6-Nitroquinazolin-4-Amine CAS 162012-67-1
(S) -N4- (3-Chloro-4-Fluorophenyl) -7-((Tetrahydrofuran-3-yl) oxy) quinazoline-4,6-DiamineCAS 314771-76-1
(S)-N- (3-Chloro-4-Fluorophenyl) -6-Nitro-7-((Tetrahydrofuran-3-yl) oxy) quinazolin-4-AmineCAS 314771-88-5
Aha Chemical | (Dimethylamino) acetaldehyde Diethyl Acetal |
Ụdị okwu | 2,2-Diethoxy-N, N-Dimethylethylamine;N- (2,2-Diethoxyethyl) dimethylamine;2,2-Diethoxy-N,N-Dimethylethan-1-Amine |
Nọmba CAS | 3616-56-6 |
Nọmba CAT | RF-PI2031 |
Ọnọdụ Ahịa | N'ọkwa, Mpụta Ihe ruru Tọn |
Usoro ihe omimi | C8H19NO2 |
Ibu molekụla | 161.25 |
Mmetụta | Mmiri nwere mmetụta |
Ebe esi nri | 60 ℃/5 mmHg |
Ebe mgbari | 45 ℃ |
Ụdị | Ruifu Chemical |
Ihe | Nkọwapụta |
Ọdịdị | Mmiri doro anya enweghị agba |
Ụzọ ịdị ọcha / nyocha | > 99.0% (GC) |
Ntụgharị ntụgharị N20/D | 1.410-1.414 |
Nnukwu ike ndọda (20/20 ℃) | 0.865-0.870 |
Ọnụ ego nke Proton NMR Spectrum | Dabara na Ọdịdị |
Mgbakọta adịghị ọcha | <1.00% |
Ọla dị arọ (dị ka Pb) | ≤20ppm |
Nlele ọkọlọtọ | Standardkpụrụ ụlọ ọrụ |
Ojiji | Ndị n'etiti ọgwụ;Afatinib Dimaleate;Sumatriptan |
ngwugwu: Klas Fluorinated, 25kg/Drum, ma ọ bụ dị ka ndị ahịa chọrọ
Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri
(Dimethylamino) acetaldehyde Diethyl Acetal (CAS: 3616-56-6) na-eji dị ka ọgwụ intermediates.(Dimethylamino) acetaldehyde Diethyl Acetal nwere ike iji mee ihe na njikọ nke Afatinib Dimaleate (CAS: 850140-73-7), Sumatriptan (CAS: 103628-46-2).Afatinib (aha ahia Gilotrif na US na Giotrif na Europe, nke mbụ Tomtovok na Tovok) bụ ọgwụ akwadoro na United States, Europe, Taiwan, Mexico, Chile na Japan yana mba ndị ọzọ maka ọgwụgwọ mbụ nke ndị ọrịa nwere iche. ụdị metastatic (EGFR mutation positive) nke na-abụghị obere cell lung carcinoma (NSCLC), nke Boehringer Ingelheim mepụtara.Afatinib na-arụ ọrụ dị ka onye na-egbochi onye na-eme ihe na-adịghị agbanwe agbanwe nke tyrosine kinases epidermal growth factor receptor (EGFR) na erbB-2 (HER2).Sumatriptan bụ triptan mbụ akwadoro (1991) maka nnukwu ọgwụgwọ isi ọwụwa migraine.Ọ nwere bioavailability dị ala n'etiti triptans niile n'ihi obere lipophilicity ya.Nnweta nke ọtụtụ usoro dosage dị iche iche (ya bụ, mbadamba ụrọ, injection SC, usoro ịgba imi, na ọgwụ suppository) na-enye ohere mgbanwe nke ịkwa akwa maka mkpa nke onye ọrịa n'otu n'otu, na-eme ka sumatriptans bụrụ ọgwụ bara uru maka nnukwu ọgwụgwọ migraine. isi ọwụwa.Sumatriptan nwekwara ngwa ngwa ngwa ngwa site na ntụtụ SC ma ọ bụ nchịkwa imi.